Nexalin names Abbott, Medtronic veteran Robert DiTota senior strategic advisor for global commercialization
Bitget2026/09/29 13:05- Nexalin Technology appointed neuromodulation executive Robert DiTota as senior strategic advisor for global commercialization, effective Sept. 15, 2026.
- DiTota will advise management on commercial strategy, international distribution, market development, go-to-market planning, commercial infrastructure, organizational buildout.
- He spent more than 20 years in neuromodulation at Abbott, most recently divisional VP of sales for North America commercial neuromodulation.
- DiTota previously worked at Medtronic for nine years, supporting deep brain stimulation in New York and the Activa platform launch.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US Dollar Index fell below the 101 mark, down 0.13% intraday.
Report: US-Iran conflict disrupts OPEC+ production increase schedule, capacity review postponed to mid-November
According to media reports, the capacity review work by OPEC+ has been delayed. Originally scheduled to be completed by the end of September 2026, it has now been postponed to mid-November. This theoretically still allows OPEC+ to discuss the related results at the plenary meeting in late November. The independent capacity assessment results will directly affect the production caps approved for each member country, and some member countries have already shown significant disagreements regarding quotas, putting pressure on the alliance’s stability.
Crypto prices
More
